Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-17 · accession 0001765581-22-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-21 | 2022-03-17 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $59.13 | +1,288 | 347.1K | +0.4% | +$76.2K |
| D | 2022-03-21 | 2022-03-17 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -1,288 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-17 | M | A | 1,288 | $59.13 | 347,134 | D | — | — | |
| 2 | Derivative | Incentive Stock Option (right to buy) | 2022-03-17 | M | D | 1,288 | $0.00 | 0 | D | $59.13 · — to 2023-03-04 | 1,288 Ordinary Shares | (F1) This incentive stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017. |